Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagun Parakh

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Asia-Pacific Journal of Clinical Oncology|March 3, 2022
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspectiveClare Senko, Ashray Gunjur, Adithya Balasubramanian, et al.
Cancer Reports (Hoboken, N.J.)|July 29, 2020
A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastasesSurein Arulananda, Sagun Parakh, Jodie Palmer, et al.
Biomedicines|May 25, 2017
Antibody-Drug Conjugates for Cancer TherapyAdam C Parslow, Sagun Parakh, Fook-Thean Lee, et al.
JTO Clinical and Research Reports|August 2, 2023
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line ChemoimmunotherapyYang Wang, Jared Mathai, Muhammad Alamgeer, et al.
Journal of Neuro-Oncology|August 6, 2022
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Neuro-Oncology|August 22, 2022
Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Thoracic Disease|August 10, 2023
Real-world challenges in undertaking <i>NTRK</i> fusion testing in non-small cell lung cancerAshleigh Poh, Abdelaziz Sammour, Jared Mathai, et al.
Neuro-Oncology Advances|February 5, 2021
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastomaAdithya Balasubramanian, Ashray Gunjur, Umbreen Hafeez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 10, 2015
Recurrent glioblastoma: Current patterns of care in an Australian populationSagun Parakh, Vicky Thursfield, Lawrence Cher, et al.
The AAPS Journal|March 10, 2018
Receptor Occupancy Imaging Studies in Oncology Drug DevelopmentIngrid J G Burvenich, Sagun Parakh, Adam C Parslow, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Asia-Pacific Journal of Clinical Oncology|March 3, 2022
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspectiveClare Senko, Ashray Gunjur, Adithya Balasubramanian, et al.
Cancer Reports (Hoboken, N.J.)|July 29, 2020
A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastasesSurein Arulananda, Sagun Parakh, Jodie Palmer, et al.
Biomedicines|May 25, 2017
Antibody-Drug Conjugates for Cancer TherapyAdam C Parslow, Sagun Parakh, Fook-Thean Lee, et al.
JTO Clinical and Research Reports|August 2, 2023
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line ChemoimmunotherapyYang Wang, Jared Mathai, Muhammad Alamgeer, et al.
Journal of Neuro-Oncology|August 6, 2022
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Neuro-Oncology|August 22, 2022
Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Thoracic Disease|August 10, 2023
Real-world challenges in undertaking <i>NTRK</i> fusion testing in non-small cell lung cancerAshleigh Poh, Abdelaziz Sammour, Jared Mathai, et al.
Neuro-Oncology Advances|February 5, 2021
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastomaAdithya Balasubramanian, Ashray Gunjur, Umbreen Hafeez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 10, 2015
Recurrent glioblastoma: Current patterns of care in an Australian populationSagun Parakh, Vicky Thursfield, Lawrence Cher, et al.
The AAPS Journal|March 10, 2018
Receptor Occupancy Imaging Studies in Oncology Drug DevelopmentIngrid J G Burvenich, Sagun Parakh, Adam C Parslow, et al.
Pageof 8